SOURCE: Xtalks

Xtalks Webinars

October 06, 2014 07:05 ET

Managing the API Life Cycle: Cambrex Innovation, Process and Cost Improvement, Live Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - October 06, 2014) - This webinar will examine how pharmaceutical companies can manage their Active Pharmaceutical Ingredient (API) life cycle through innovation, process and cost improvements in order to meet clinical and commercial objectives and to help move their products quickly to market. Join this webinar to learn more on Thursday, October 16, 2014 at 11am EDT (NA) / 4pm BST (UK GMT+1). 

The manufacturing strategy of an API needs to be carefully configured to support all points in its life cycle. Whether an API is in an introduction, growth or maturity phase will decisively determine its manufacturing process requirements. In this webinar, the presenters will use case studies to examine how Cambrex manages the API life cycle through innovation, process and cost improvement. By carefully considering a customer's API life cycle prerequisites, Cambrex can provide large, mid-size and emerging pharmaceutical companies additional opportunities to meet their changing small molecule needs. Ultimately, this helps bring customers' products to market quickly while supporting the API life cycle through to maturity.

Join the panel from Cambrex including Jonathan Knight, Vice President of New Product Development, Margus Eek, Head of Research and Development (Cambrex Tallinn), and Lars Eklund, Technical Lead, as they detail their objective and describe how customers can benefit from their innovative approach to develop new sustainable routes or processes, by which additional IP protection can be generated, cost of goods lessened, and/or environmental footprints reduced.

To learn more about this event visit: Managing the API Life Cycle: Cambrex Innovation, Process and Cost Improvement.

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include biocatalysis, high potency APIs, high energy chemical synthesis, controlled substances and drug product formulations. For more information, please visit www.cambrex.com.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2014/10/3/11G023163/Images/Cambrex_Logo_PMS_300-62020537413.jpg

Contact Information

  • Contact:
    Michelle Tran
    Tel: +1 (416) 977-6555 ext 352
    Email: mtran(at)xtalks(dot)com